The impact of immunotherapy in patients with advanced non-melanoma skin cancer: Focusing in on patient identification and treatment optimization

Friday, March 25


Ai Cme2x

Join Drs. Chrysalyn Schmults and Ann Silk as they discuss the clinical application of the novel immunotherapeutic agents for patients with non-melanoma skin cancer with personal perspectives from Dale Biggs, a patient who was treated for advanced cutaneous squamous cell carcinoma. As new options bring new hope for patients with non-melanoma skin cancer, come listen to how the experts in care implement personalized approaches in their practice to enhance patient outcomes and optimize treatment protocols.

Supported by: An independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

When: Friday, March 25 | 6:30 p.m. Registration | 7:00 p.m. Program

Where: Pacific Grand Ballroom DE | Renaissance Boston Waterfront Hotel